Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed early-phase tilt small index

Myofascial Trigger Point Pain: early-phase trial registry

A small indexed set (3 trials) with no open enrollment listed right now.

Corpus placement: #5,209 of 28,707 conditions by registered trial count.

3 US clinical trials · none currently recruiting · #5,209 of 28,707 conditions by registered trial count

Myofascial Trigger Point Pain: 3 US clinical trials tracked, none currently recruiting.

Myofascial Trigger Point Pain is the subject of 3 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is North Dakota State University, running 2 of these trials.

Enrollment posture brief

Registry condition myofascial-trigger-point-pain

OPEN 0 | RECR 0% | LATE 0 | EARLY 1 | RANK #5209 | SPON 2

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Myofascial Trigger Point (th…0%
Open-enrollment share among volume-matched conditions near Myofascial Trigger Point Pain

Myofascial Trigger Point Pain has no open enrollment in this registry pull (3 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Myofascial Trigger Point Pain on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Myofascial Trigger Point Pain is recruiting below its size-band peers.

    0 of 3 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11

Phase Distribution

PhaseTrial count
Phase 1 1

Named interventions

Most-linked intervention names on Myofascial Trigger Point Pain records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Kinesio® Tape Device
1 trials
Kinesio® Tape Other
1 trials
OnabotulinumtoxinA Drug
1 trials
Placebo Drug
1 trials

US sites by state

Facility locations filed on Myofascial Trigger Point Pain trials. A trial with sites in several states counts in each.

North Dakota 2 trials
Ohio 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Myofascial Trigger Point Pain page

3 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Myofascial Trigger Point Pain trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • North Dakota State University sponsors the most Myofascial Trigger Point Pain trials on record, review their full trial history before evaluating a specific study. See North Dakota State University's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Myofascial Trigger Point Pain condition card totals 3 registered trials; most-linked intervention Kinesio® Tape; top US site state North Dakota. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.